Zynex Inc P/FCF
¿Qué es el P/FCF de Zynex Inc?
El P/FCF de Zynex Inc es 31.01
¿Cuál es la definición de P/FCF?
El precio a flujo de caja libre (P / FCF) es una métrica de valoración que compara el precio actual de las acciones de la compañía con su flujo de caja libre por acción.
Price to free cash flow (P/FCF) is a measure that value investors find useful to analyze a company’s finances in relation to its current stock price. It is a stricter measure than the price to cash flow ratio as it subtracts capital expenditures from cash flow.
Free cash flow relies heavily on the state of a company's cash from operations, which is in turn heavily influenced by the company's net income. Companies can manipulate their free cash flow by lengthening the time they take to pay their bills, shortening the time it takes to collect what's owed to them, and putting off buying inventory. It also depends on what items are considered capital expenditures and this can be different in case of different companies.
Lower values of P/FCF generally indicate a company that is undervalued and whose stock is relatively cheap in relation to its free cash flow. Conversely, higher P/FCF indicate that the company's stock is relatively overvalued. Value investors thus favor companies with low or decreasing price to free cash flow values that indicate high or increasing free cash flow totals and relatively low stock share prices.
It is best to compare price to free cash flow ratios between similar companies in the same industry. However, the P/FCF metric can also be viewed over a longer time frame to see if the company's cash flow to share price value is improving or declining.
P/FCF de compañías en Sector Health Care en NASDAQ en comparadas con Zynex Inc
¿Qué hace Zynex Inc?
zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.
Empresas con p/fcf similar a Zynex Inc
- Appotronics tiene P/FCF de 30.91
- TR European Growth Trust Plc tiene P/FCF de 30.94
- Mastercard tiene P/FCF de 30.94
- S&P Global tiene P/FCF de 30.97
- SAP SE tiene P/FCF de 30.97
- Paychex tiene P/FCF de 30.97
- Zynex Inc tiene P/FCF de 31.01
- Colliers International tiene P/FCF de 31.02
- Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund tiene P/FCF de 31.07
- Kneat.Com Inc tiene P/FCF de 31.09
- Toro Co tiene P/FCF de 31.09
- The UNITE Plc tiene P/FCF de 31.15
- bioMérieux SA tiene P/FCF de 31.15